Table 1 Overview of validation and quantitation experiments
CPTAC experiment | Outcome | Plasma samplea | Standard (fmol on LC column for each injection)b | Normalizer (fmol on LC column for each injection)b | Experimental designc |
---|---|---|---|---|---|
1 | Response curve | Pooled (N = 30)d | SIS 20,000 to 0.16; dilution pattern: 1:10:10:5:2:2:2:2:2:2:2:2 | NAT 200 | Digested sample was spiked with serial dilutions of SIS peptides and analyzed on the same day |
2 | Validation of assay repeatability | Pooled (N = 30)d | SIS 2.5× and 5× (low), 50× (medium), and 500× (high) assay LLOQ | NAT 200 | Five aliquots of the same digested sample were spiked and analyzed on five different days |
3 | Assessment of assay selectivity | Individual (N = 6)d | NAT no spike, 50×, and 500× assay LLOQ | SIS 100× assay LLOQ | Six biological replicates of the digested matrix were spiked and analyzed on the same day. |
4 | Validation of assay stability | Pooled (N = 30)d | SIS 100× assay LLOQ | NAT 200 | Six aliquots of the digested and spiked sample were analyzed after being stored at 4 and −80 °C for various periods of time |
5 | Reproducible detection of the endogenous analyte | Pooled (N = 30d | – | SIS 100× assay LLOQ | Five aliquots of the same sample were digested, spiked, and analyzed on five different days |
Quantitation | Reference range of target protein concentrations | Individual (N = 6 for each strain)e | – | SIS 100× assay LLOQ | Individual samples were digested, spiked, and analyzed. Concentration ranges of endogenous analytes were determined using a calibration curve prepared in a surrogate matrix |